Publication Name	World Journal of Psychiatry
Manuscript ID	4372
Country	Spain

Received	2013-06-28 11:48
Peer-Review Started	2013-06-28 17:52
First Decision by Editorial Office Director
Return for Revision	2013-07-19 21:57
Revised	2013-08-10 16:37
Publication Fee Transferred
Second Decision by Editor	2013-11-01 16:43
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2013-11-03 11:09
Articles in Press
Edit the Manuscript by Language Editor
Typeset the Manuscript	2013-11-19 14:14
Publish the Manuscript Online	2014-01-11 22:13

ISSN	2220-3206 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Psychiatry
Manuscript Type	Review
Article Title	Brain-derived neurotrophic factor as a potential biomarker of cognitive recovery in schizophrenia
Manuscript Source	Invited Manuscript
All Author List	Rafael Penadés, Rosa Catalán, Irene López-Vílchez, Bárbara Arias, Alexandre González-Rodríguez, Ana M Galán and Cristóbal Gastó
Funding Agency and Grant Number	Funding Agency Grant Number Instituto de Salud Carlos III of FIS PI 11/01958 CIBERSAM to Penadés R
Corresponding Author	Dr. Rafael Penadés, PhD, Psychiatry and Psychology, Clinical Institute of Neurosciences (ICN), Hospital Clínic, C/ Villarroel 170, 08036 Barcelona, Spain. rpenades@clinic.ub.es
Key Words	Schizophrenia; Brain-derived neurotrophic factor; Cognition; Biomarkers
Core Tip	The lack of diagnostic and treatment markers is one of the most important problems in clinical practice. Brain-derived neurotrophic factor (BDNF) has been proposed as a biomarker of schizophrenia and, more specifically, as a biomarker of cognitive recovery. Evidence collected in this review indicates that there is evidence suggesting that serum BDNF levels are involved in some synaptic plasticity processes. Additionally, serum BDNF levels significantly increased in schizophrenia subjects after neuroplasticity-based cognitive training. All in all, the current consideration of BDNF as a biomarker of cognitive recovery in schizophrenia is promising but still premature.
Publish Date	2014-01-11 22:13
Citation	Penadés R, Catalán R, López-Vílchez I, Arias B, González-Rodríguez A, Galán AM, Gastó C. Brain-derived neurotrophic factor as a potential biomarker of cognitive recovery in schizophrenia. World J Psychiatr 2013; 3(4): 93-102
URL	http://www.wjgnet.com/2220-3206/full/v3/i4/93.htm
DOI	http://dx.doi.org/10.5498/wjp.v3.i4.93

Full Article (PDF)	WJP-3-93.pdf
Full Article (Word)	WJP-3-93.doc
Manuscript File	4372-Review.doc
Answering Reviewers	4372-Answering reviewers.pdf
Copyright License Agreement	4372-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	4372-Language certificate.pdf
Peer-review Report	4372-Peer review(s).pdf
Scientific Editor Work List	4372-Scientific editor work list.doc